Weigh To Go Weight Loss Center

Weigh To Go Weight Loss Center operates in Knoxville, Tennessee, under the clinical direction of Mark Smith, PA-C, MPAS, DMS, who holds National Board Certification through the NCCPA and maintains active memberships in the American Academy of Physician Assistants, American Academy of Anti-Aging Medicine, and American Board of Longevity Medicine and Sciences. The clinic provides medically-supervised weight management programs that integrate metabolic health assessment, hormone optimization, and pharmaceutical interventions designed for patients who have not achieved results through diet and exercise alone. Each patient undergoes comprehensive metabolic testing and body composition analysis before beginning treatment, allowing the clinical team to identify underlying factors such as insulin resistance, thyroid dysfunction, or hormonal imbalances that may impede weight loss.

The center's pharmaceutical weight loss protocols include tirzepatide and semaglutide, both GLP-1 receptor agonists that work by regulating appetite, slowing gastric emptying, and improving insulin sensitivity. Tirzepatide, a dual GIP/GLP-1 receptor agonist, is prescribed for patients requiring more aggressive metabolic intervention, while semaglutide serves as an effective option for those with moderate weight loss goals or specific contraindications. These medications are administered via subcutaneous injection on a weekly schedule, with dosing titrated based on individual tolerance and response. The clinic also incorporates NAD+ (nicotinamide adenine dinucleotide) therapy to support cellular energy production, enhance metabolic function, and address age-related decline in mitochondrial efficiency. NAD+ is delivered through intravenous infusion protocols that range from single sessions to multi-week courses depending on patient goals related to energy restoration, cognitive function, and metabolic optimization.

Mark Smith's training in anti-aging and longevity medicine informs the clinic's approach to hormone replacement therapy, which addresses deficiencies in testosterone, estrogen, progesterone, and thyroid hormones that commonly contribute to weight gain, fatigue, and metabolic slowdown. Hormone panels are ordered through LabCorp or Quest Diagnostics, and replacement protocols use bioidentical hormones when clinically appropriate. The clinic treats men experiencing andropause-related weight gain and women navigating perimenopause or menopause who present with stubborn abdominal fat, muscle loss, and energy decline. Hormone optimization is coordinated with weight loss medications to create synergistic metabolic improvements, and patients receive ongoing monitoring through follow-up lab work and clinical assessments every 8 to 12 weeks.

Patients at Weigh To Go Weight Loss Center attend in-person consultations at the Knoxville facility, where initial visits include a full medical history review, physical examination, body composition scan, and discussion of weight loss goals and previous attempts. Follow-up appointments occur every two to four weeks during active weight loss phases, allowing the clinical team to adjust medication dosing, review dietary adherence, and address side effects such as nausea or gastrointestinal discomfort that can occur with GLP-1 therapies. The clinic provides nutritional guidance focused on high-protein, low-glycemic meal planning and offers optional IV hydration therapy sessions that deliver electrolytes, B vitamins, and amino acids to support patients experiencing dehydration or nutrient depletion during caloric restriction. Aesthetic medicine services, including treatments for skin laxity and body contouring concerns that may arise during significant weight loss, are available as adjunctive options for patients seeking comprehensive body transformation support.

Weigh To Go Weight Loss Center's 4.7-star Google rating across 51 reviews reflects patient feedback on the accessibility of the Knoxville location, the thoroughness of Mark Smith's clinical assessments, and the structured accountability provided through regular in-person follow-ups. The clinic does not offer telehealth consultations, which ensures that all patients receive hands-on clinical evaluation and direct access to the provider team throughout their treatment course. This in-person model allows for real-time adjustments to medication protocols, immediate management of adverse effects, and the integration of multiple treatment modalities—including hormone therapy, peptide administration, and IV nutrient support—under one clinical roof. Patients seeking medically-supervised weight loss in the Knoxville area will find a practice that combines pharmaceutical intervention with metabolic and hormonal optimization, delivered by a provider with specialized training in longevity medicine and anti-aging therapeutics.